By Professor Adam Jaffe

Journal articles

Weinberger M; Bryon M; Jaffé A; Morice A; Ojoo J; Kastelik J, 2003, 'Disabling cough: Habit disorder or tic syndrome? [7] (multiple letters)', Lancet, 361, pp. 1991 - 1992, http://dx.doi.org/10.1016/S0140-6736(03)13570-2

Bryon M; Jaffé A, 2003, 'Disabling cough: habit disorder or tic syndrome?', Lancet, 361, pp. 1991 - 1992, http://dx.doi.org/10.1016/S0140-6736(03)13571-4

Spencer H; Jaffe A, 2003, 'Newer therapies for cystic fibrosis', Current Paediatrics, 13, pp. 259 - 263, http://dx.doi.org/10.1016/S0957-5839(03)00030-7

Cohen G; Hjortdal V; Ricci M; Jaffe A; Wallis C; Dinwiddie R; Elliott MJ; De Leval MR; Laudito A; Wood D, 2003, 'Primary thoracoscopic treatment of empyema in children', Journal of Thoracic and Cardiovascular Surgery, 125, pp. 79 - 84, http://dx.doi.org/10.1067/mtc.2003.88

Sit SC; Cohen G; Jaffe A; Thomson AH; Hull J, 2003, 'Urokinase in the treatment of childhood empyema [5] (multiple letters)', Thorax, 58, pp. 93 - 94, http://dx.doi.org/10.1136/thorax.58.1.93

Jaffé A; Buchdahl R; Bush A; Balfour-Lynn IM, 2002, 'Are annual blood tests in preschool cystic fibrosis patients worthwhile?', Archives of Disease in Childhood, 87, pp. 518 - 520, http://dx.doi.org/10.1136/adc.87.6.518

Jaffé A; Rosenthal M, 2002, 'Macrolides in the respiratory tract in cystic fibrosis', Journal of the Royal Society of Medicine Supplement, 95, pp. 27 - 31

Jaffe A; Balfour-Lynn IM, 2002, 'Treatment of severe small airways disease in children with cystic fibrosis: Alternatives to corticosteroids', Pediatric Drugs, 4, pp. 381 - 389, http://dx.doi.org/10.2165/00128072-200204060-00005

Jaffé A, 2001, 'The anti-inflammatory effects of macrolides in cystic fibrosis', Japanese Journal of Antibiotics, 54, pp. 77 - 82

Jaffé A; Hamutcu R; Dhawan RT; Adler B; Rosenthal M; Bush A, 2001, 'Routine ventilation scans in children with cystic fibrosis: Diagnostic usefulness and prognostic value', European Journal of Nuclear Medicine, 28, pp. 1313 - 1318, http://dx.doi.org/10.1007/s002590100573

Jaff A; Bush A, 2001, 'Anti-inflammatory effects of macrolides in lung disease', Pediatric Pulmonology, 31, pp. 464 - 473, http://dx.doi.org/10.1002/ppul.1076

Jaffé A; Bush A, 2001, 'Cystic fibrosis: Review of the decade', Monaldi Archives for Chest Disease, 56, pp. 240 - 247

Jaffé A; Bush A, 2001, 'Genetic contributions to rare childhood lung diseases', Paediatric Respiratory Reviews, 2, pp. 268 - 275, http://dx.doi.org/10.1053/prrv.2001.0150

Braga ALF; Saldiva PHN; Pereira LAA; Menezes JJC; Conceição GMS; Lin CA; Zanobetti A; Schwartz J; Dockery DW, 2001, 'Health effects of air pollution exposure on children and adolescents in São Paulo, Brazil', Pediatric Pulmonology, 31, pp. 106 - 113, http://dx.doi.org/10.1002/1099-0496(200102)31:2<106::AID-PPUL1017>3.0.CO;2-M

Davies JC; Davies MG; Smith S; Jaffe A; Bush A; Scallon M; Geddes DM; Alton EWFW, 2000, 'Confirmation of abnormal chloride ion secretion in the lower airway of children with cystic fibrosis', Thorax, 55, pp. A67

Jaffé A; Judd D; Ratcliffe C; Cheng SH; Bush A; Geddes DM; Alton EWFW, 2000, 'Cationic lipid-mediated gene transfer to the growing murine and human airway', Gene Therapy, 7, pp. 273 - 278, http://dx.doi.org/10.1038/sj.gt.3301091

Payne DNR; Adcock IM; McKenzie SA; Oates T; Wilson NM; Jaffe AD; Scallon M; Bush A, 1999, 'Corticosteroid insensitive asthma in children', Thorax, 54, pp. A6

Jaffé A; Bush A, 1999, 'If you can't stand the rash, get out of the kitchen: An unusual adverse reaction to ciprofloxacin', Pediatric Pulmonology, 28, pp. 449 - 450, http://dx.doi.org/10.1002/(SICI)1099-0496(199912)28:6<449::AID-PPUL11>3.0.CO;2-H

Alton EWFW; Stern M; Farley R; Jaffe A; Chadwick SL; Phillips J; Davies J; Smith SN; Browning J; Davies MG; Hodson ME; Durham SR; Li D; Jeffery PK; Scallan M; Balfour R; Eastman SJ; Cheng SH; Smith AE; Meeker D; Geddes DM, 1999, 'Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: A double-blind placebo-controlled trial', Lancet, 353, pp. 947 - 954, http://dx.doi.org/10.1016/S0140-6736(98)06532-5

Thomas SR; Jaffe A; Geddes DM; Hodson ME; Alton EWFW, 1999, 'Pulmonary disease severity in men with ΔF508 cystic fibrosis and residual chloride secretion', Lancet, 353, pp. 984 - 985, http://dx.doi.org/10.1016/S0140-6736(98)05447-6

Jaffe A; Bush A, 1999, 'Cystic fibrosis: A management update', Prescribers Journal, 39, pp. 91 - 96

Jaffé A; Bush A; Geddes DM; Alton EWFW, 1999, 'Prospects for gene therapy in cystic fibrosis', Archives of Disease in Childhood, 80, pp. 286 - 289, http://dx.doi.org/10.1136/adc.80.3.286

Smith SN; Middleton PG; Chadwick S; Jaffe A; Bush KA; Rolleston S; Farley R; Delaney SJ; Wainwright B; Geddes DM; Alton EWFW, 1999, 'The in vivo effects of milrinone on the airways of cystic fibrosis mice and human subjects', American Journal of Respiratory Cell and Molecular Biology, 20, pp. 129 - 134, http://dx.doi.org/10.1165/ajrcmb.20.1.3278

Jaffe A; Judd D; Bush A; Cheng SH; Geddes DM; Alton EWFW, 1998, 'Cationic lipid-mediated gene transfer to the growing murine airway', Thorax, 53, pp. A78

Phillips GE; Pike S; Jaffe A; Bush A, 1998, 'Comparison of the active cycle of breathing techniques and external high frequency oscillation jacket for clearance of secretions in children with cystic fibrosis', Thorax, 53, pp. A61

Jaffé A; Francis J; Rosenthal M; Bush A, 1998, 'Long-term azithromycin may improve lung function in children with cystic fibrosis', Lancet, 351, pp. 420, http://dx.doi.org/10.1016/S0140-6736(05)78360-4

Davies J; Jaffé A; Bush A, 1998, 'Distal 10q trisomy syndrome with unusual cardiac and pulmonary abnormalities', Journal of Medical Genetics, 35, pp. 72 - 74, http://dx.doi.org/10.1136/jmg.35.1.72

Stern M; Phillips J; Jaffe A; Farley R; Chadwick S; Davies J; Smith S; Browning J; Hodson ME; Durham S; Li D; Jeffery P; Scallah M; Balfour R; Cheng S; Smith A; Meeker D; Geddes DM; Alton EWFW, 1997, 'A double blind placebo controlled trial of pulmonary and nasal administration of liposome-mediated CFTR gene transfer in CF subjects', Thorax, 52, pp. A3

Jaffé A; Francis J; Bush A; Rosenthal M, 1997, 'Long term azithromycin improves lung function in children with cystic fibrosis', Thorax, 52, pp. A42

Conference Papers

Shanmugarajan S; Coward E; McBride J; Field P; Jaffe A; Chuang S, 2023, 'Long Term Pulmonary Outcomes in Children With Congenital Lung Malformations', American Thoracic Society, Washington DC, pp. a2946 - a2946, presented at B27. EVOLVING CONCEPTS IN LUNG FUNCTION TESTING AND MONITORING, Washington DC, 19 May 2023 - 24 May 2023, http://dx.doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a2946

Fawcett LK; Jaffe A; Waters SA, 2023, 'WS14.02 Cystic fibrosis personalised medicine; paediatric in vitro airway cell models to predict CFTR modulator patient outcomes', in Journal of Cystic Fibrosis, Elsevier BV, pp. S28 - S28, http://dx.doi.org/10.1016/s1569-1993(23)00266-7

Homaira N; Hu N; Owens L; Chan M; Gray M; Britton P; Selvaduri H; Lingam R; Jaffe A, 2022, 'Impact of lockdowns on paediatric asthma hospital presentations over three waves of COVID-19 pandemic', in EUROPEAN RESPIRATORY JOURNAL, EUROPEAN RESPIRATORY SOC JOURNALS LTD, SPAIN, Barcelona, presented at International Congress of the European-Respiratory-Society (ERS), SPAIN, Barcelona, 04 September 2022 - 06 September 2022, http://dx.doi.org/10.1183/13993003.congress-2022.2455

Plush L; McBride J; Belesses Y; Fawcett L; Mechin Y; Jaffe A, 2021, 'UTILIZING MULTIPLE BREATH WASHOUT TO MONITOR CHANGES IN AIRWAY FUNCTION IN CHILDREN WITH CYSTIC FIBROSIS AFTER COMMENCING ORKAMBId (R) OR SYMDEKO', in RESPIROLOGY, WILEY, pp. 4 - 4, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000644657800004&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hewson C; Wong S; Awatade N; Bridge W; Jaffe A; Waters S, 2020, 'A NOVEL COMPOUND FOR CYSTIC FIBROSIS THERAPY, TARGETING THE PROTEOSTASIS NETWORK', in Respirology, Wiley, Melbourne, Australia_Cancelled due to COVID-19, presented at TSANZ20_The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health, Melbourne, Australia_Cancelled due to COVID-19, http://dx.doi.org/10.1111/resp.13777

Fawcett L; Wakefield C; Widger J; Jaffe A; Waters S, 2020, 'ACCEPTABILITY OF USING PERSONALISED MINI‐ORGAN‐AVATARS TO ACCELERATE DRUG DISCOVERY AND PREDICT DRUG RESPONSE IN CYSTIC FIBROSIS PATIENTS', in TSANZSRS 2020 The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science, Melbourne - cancelled due to COVID, presented at TSANZSRS 2020, Melbourne - cancelled due to COVID, http://dx.doi.org/10.1111/resp.13778

Allan K; Awatade N; Wong S; Jaffe A; Waters S, 2020, 'COMBINATION THERAPY ORKAMBI® (VX‐770/VX‐809) IMPROVES FUNCTION FOR A RARE CFTR MUTATION R117H IN PATIENT‐DERIVED AIRWAY CELL MODELS', in Respirology, Wiley, Melbourne - cancelled due to COVID., presented at TSANZ20_The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health, Melbourne - cancelled due to COVID., http://dx.doi.org/10.1111/resp.13777

Wong S; Awatade N; Jaffe A; Waters S, 2020, 'ESTABLISHING PATIENT‐DERIVED NASAL SPHEROIDS AS A NON‐INVASIVE PERSONALISED MODEL FOR ASSESSING CFTR MODULATORS EFFECTIVENESS IN PATIENTS WITH CF', in Respirology, Wiley, Melbourne, Australia_Cancelled due to COVID-19, presented at TSANZ20_The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health, Melbourne, Australia_Cancelled due to COVID-19, http://dx.doi.org/10.1111/resp.13778

Wong S; Awatade N; Fawcett L; Ooi KC; Jaffe A; Waters S, 2020, 'FUNCTIONAL AND PHARMACOLOGICAL CHARACTERIZATION OF RARE R352Q CFTR MUTATION IN PATIENT‐DERIVED DIFFERENTIATED NASAL EPITHELIAL CELLS AND INTESTINAL ORGANOIDS', in Respirology, Wiley, Melbourne, Australia_Cancelled due to COVID-19, presented at TSANZ20_The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health, Melbourne, Australia_Cancelled due to COVID-19, http://dx.doi.org/10.1111/resp.13777

Awatade NIO; Wong S; Jaffe A; Ooi KC; Waters S, 2020, 'INTESTINAL CURRENT MEASUREMENT AS DIAGNOSTIC AND SURROGATE MARKER OF CFTR FUNCTION IN CF', in Respirology, Wiley, Melbourne, Australia_Cancelled due to COVID-19, presented at INTESTINAL CURRENT MEASUREMENT AS DIAGNOSTIC AND SURROGATE MARKER OF CFTR FUNCTION IN CF, Melbourne, Australia_Cancelled due to COVID-19, http://dx.doi.org/10.1111/resp.13777

Allan K; Awatade N; Wong S; Turgutoglu N; Jaffe A; Waters S, 2020, 'COMBINATION THERAPY ORKAMBI (R) (VX-770/VX-809) IMPROVES FUNCTION FOR A RARE CFTR MUTATION R117H IN PATIENT-DERIVED AIRWAY CELL MODELS', in RESPIROLOGY, WILEY, pp. 36 - 36, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000538684200067&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Shim S; Chan M; Owens L; Jaffe A; Prentice B; Homaira N, 2020, 'OSELTAMIVIR FOR INFLUENZA TREATMENT IN CHILDREN WITH CHRONIC LUNG DISEASES', in RESPIROLOGY, WILEY, pp. 225 - 225, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000538684200438&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Plush L; Mcbride J; Fawcett L; Mechin Y; Jaffe A, 2020, 'UTILISING MULTIPLE BREATH WASHOUT (MBW) TO MONITOR CHANGES IN AIRWAY FUNCTION IN CHILDREN WITH CYSTIC FIBROSIS (CF) AFTER COMMENCING ORKAMBI (R)', in RESPIROLOGY, WILEY, pp. 3 - 3, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000538684200003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lin B; Kennedy B; McBride J; Dalla-Pozza L; Trahair T; McCowage G; Coward E; Plush L; Robinson PD; Hardaker K; Widger J; Ng A; Jaffe A; Selvadurai H, 2019, 'Long-term morbidity of respiratory viral infections during chemotherapy in children with leukaemia', in Pediatric Pulmonology, Wiley, United States, pp. 1821 - 1829, United States, http://dx.doi.org/10.1002/ppul.24456

Waters S; Villamizar O; Jaffe A; Morris K, 2019, 'Targeted Activation of Cystic Fibrosis Transmembrane Conductance Regulator', in Targeted Activation of Cystic Fibrosis Transmembrane Conductance Regulator, WILEY, pp. S183 - S184, presented at 33rd Annual North American Cystic Fibrosis Conference, http://dx.doi.org/10.26190/unsworks/27426

McKay IR; Coffey MJ; Doumit M; Bramley L; Sharp M; Kasparian N; Chuang S; Stelzer-Braid S; Waters S; Thomas T; Jaffe A; Katz TE; Ooi CY, 2019, 'A GUT FEELING: CORRELATING DIETARY INTAKE WITH THE GASTROINTESTINAL AND RESPIRATORY MICROBIOTA IN CYSTIC FIBROSIS', in PEDIATRIC PULMONOLOGY, WILEY, pp. S261 - S262, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000484544000375&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Coffey MJ; Zhong L; Jaffe A; Ooi CY; Waters S, 2019, 'THE INTESTINAL PROTEOME IN CHILDREN WITH CYSTIC FIBROSIS DIFFERS FROM HEALTHY CONTROLS', in PEDIATRIC PULMONOLOGY, WILEY, pp. S265 - S265, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000484544000385&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Coffey MJ; Zhong L; Jaffe A; Ooi CY; Waters S, 2019, 'THE HUMAN INTESTINAL PROTEOME IN CHILDREN WITH CYSTIC FIBROSIS', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, CA, San Diego, pp. S1153 - S1153, presented at Digestive Disease Week (DDW), CA, San Diego, 18 May 2019 - 21 May 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000467106004413&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Fawcett L; Turgutoglu N; Awatade N; Wong S; Widger J; Jaffe A; Waters S, 2019, 'COMPARISON OF TWO DIFFERENT CYTOLOGY BRUSHES FOR COLLECTION OF NASAL MUCOSAL CELLS', in RESPIROLOGY, WILEY, pp. 115 - 115, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000461458900217&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Waters S; Awatade N; Wong S; Hewson C; Fawcett L; Ooi K; Widger J; Jaffe A, 2019, 'TRANSFORMATIVE THERAPIES FOR ULTRA-RARE CFTR MUTATIONS IN PRIMARY PRE-CLINICAL MODELS', in RESPIROLOGY, WILEY, pp. 141 - 141, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000461458900268&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Coffey MJ; Zhong L; Jaffe A; Ooi CY; Waters S, 2019, 'Tu1872 – The Human Intestinal Proteome in Children with Cystic Fibrosis', in Gastroenterology, Elsevier BV, pp. S - 1153, http://dx.doi.org/10.1016/s0016-5085(19)39855-5

Back to profile page